A renaissance of neural networks in drug discovery

II Baskin, D Winkler, IV Tetko - Expert opinion on drug discovery, 2016 - Taylor & Francis
Introduction: Neural networks are becoming a very popular method for solving machine
learning and artificial intelligence problems. The variety of neural network types and their …

Interpretation of quantitative structure–activity relationship models: past, present, and future

P Polishchuk - Journal of Chemical Information and Modeling, 2017 - ACS Publications
This paper is an overview of the most significant and impactful interpretation approaches of
quantitative structure–activity relationship (QSAR) models, their development, and …

The history and development of quantitative structure-activity relationships (QSARs)

JC Dearden - Oncology: breakthroughs in research and practice, 2017 - igi-global.com
It is widely accepted that modern QSAR began in the early 1960s. However, as long ago as
1816 scientists were making predictions about physical and chemical properties. The first …

In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International …

F Lombardo, PV Desai, R Arimoto… - Journal of Medicinal …, 2017 - ACS Publications
In silico tools to investigate absorption, distribution, metabolism, excretion, and
pharmacokinetics (ADME-PK) properties of new chemical entities are an integral part of the …

PyDescriptor: A new PyMOL plugin for calculating thousands of easily understandable molecular descriptors

VH Masand, V Rastija - Chemometrics and Intelligent Laboratory Systems, 2017 - Elsevier
Abstract The field of Quantitative Structure-Activity Relationship (QSAR) relies heavily on
molecular descriptors. Among various guidelines suggested by Organisation for Economic …

Matched molecular pair analysis in drug discovery: methods and recent applications

Z Yang, S Shi, L Fu, A Lu, T Hou… - Journal of Medicinal …, 2023 - ACS Publications
Matched molecular pair analysis (MMPA) is a tool to extract knowledge of medicinal
chemistry from existing experimental data, and it relates changes in activities or properties to …

Toward Application and Implementation of in Silico Tools and Workflows within Benign by Design Approaches

S Lorenz, AK Amsel, N Puhlmann… - ACS Sustainable …, 2021 - ACS Publications
To avoid adverse side effects of chemicals, pharmaceuticals, and their transformation
products (TPs) in the environment, substances should be designed to fully mineralize in the …

OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds

J Yi, S Shi, L Fu, Z Yang, P Nie, A Lu, C Wu, Y Deng… - Nature …, 2024 - nature.com
Lead optimization is a crucial step in the drug discovery process, which aims to design
potential drug candidates from biologically active hits. During lead optimization, active hits …

Applications of deep-learning in exploiting large-scale and heterogeneous compound data in industrial pharmaceutical research

L David, J Arús-Pous, J Karlsson, O Engkvist… - Frontiers in …, 2019 - frontiersin.org
In recent years, the development of high-throughput screening (HTS) technologies and their
establishment in an industrialized environment have given scientists the possibility to test …

Progress in visual representations of chemical space

DI Osolodkin, EV Radchenko, AA Orlov… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: The concept of 'chemical space'reveals itself in two forms: the discrete set of all
possible molecules, and multi-dimensional descriptor space encompassing all the possible …